BDSX Biodesix Inc: ערך חשבונאי למניה

Biodesix, Inc. (BDSX) proprietary tests offer high clinical value, although Medicare limits pricing power. The trend in book value per share visualizes capital dynamics, where 0.88 captures the current state of the parameter. The integration of diagnostics into treatment protocols ensures stable revenue, yet high marketing expenses and pressure from insurers hinder the company from reaching break-even.

Book value per share is calculated as the difference between total assets and liabilities divided by the number of shares outstanding, reflecting the actual value of an investor's stake. For Biodesix, Inc. (BDSX), which invests in AI algorithms for lung cancer diagnostics, this indicator confirms the effectiveness of its intellectual property capitalization, as clearly demonstrated by the historical book value per share trend.